Most Recent
Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's top-selling antipsychotic Abilify.
The makers of Grand Theft Auto have largely succeeded in a copyright case against the developer behind the "Infamous Mod" -- a hack that alters the capabilities of players in the online version of the top-selling game.
The High Court has rejected Aristocrat's request that it rule again on the patentability of its popular Lightning Link game, after a differently comprised court was split on when computer-implemented inventions can be patented.
Defunct Westpac mortgage broker RAMS has reached a settlement in a trade mark stoush with fund manager Real Asset Management.
Despite failing a second time to make the deadline, Advanta Seeds has won an extension to pay a renewal fee for its patent for a lucrative hybrid canola plant cell.
Online fashion retailer FWRD has lost its challenge to registration of the 'FFWD' trade mark by data processing software company Corezero.
Swiss aircraft manufacturer Pilatus has won discovery to pursue a possible copyright claim stemming from a Royal Australian Air Force flight simulator contract.
A patent examiner who questioned IP Australia's examination processes has lost his appeal of a Fair Work Commission decision that found he was not forced to resign from his job.
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.
Radio manufacturer Hytera wants the High Court to hear its appeal of a finding that it misappropriated Motorola's source code in a case of "substantial industrial theft”.